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Pertussis toxin binds target cells through the carbohydrate recognition properties of two subunits, 
$2 and $3, which share amino acid sequence similarity with the lectin domains of the eukaryotic 
selectin family. Selectins appear on inflammed endothelial cells and promote rolling of leukocytes 
by reversibly binding carbohydrates. $2, $3, and synthetic peptides representing their carbohydrate 
recognition domains competitively inhibited adherence of neutrophils to selectin-coated surfaces 
and to endothelial cells in vitro. These proteins and peptides also rapidly upregulated the function 
of the leukocyte integrin CD11b/CD18. These findings implicate mimickry of eukaryotic selectins 
by prokaryotic adhesive ligands and link the mechanisms underlying leukocyte trafficking to 
microbial pathogenesis. 
F 
~roper cell traffcking in eukaryotic systems involves rec- 
ognition of addresses encoded in cell surface carbohydrates. 
A cell-cell recognition system similar in principle operates 
during infections to assure colonization of the host and proper 
tissue tropism of the pathogen. While most bacteria recog- 
nize a highly restricted range of eukaryotic cellular carbohy- 
drates (1), a few display more complex adhesins capable of 
multivalent binding to carbohydrates or proteins, a motif that 
is reminiscent of eukaryotic cells (2). Bordetella pertussis, the 
etiologic agent of whooping cough, attaches to cilia and mac- 
rophages of the human respiratory tract via two multivalent 
proteins, filamentous hemagglutinin (FHA) 1 and pertussis 
toxin (PT) (3-6). PT has been shown to cooperate with FHA 
in promoting uptake of bacteria into macrophages (7). This 
effect is linked to the ability of FHA to recognize the inte- 
grin CD11b/CD18 on leukocytes (4) and suggests the inter- 
action of FT ~ ith the leukocyte might lead to the upregula- 
tion of this integrin. The fact that the CD18 integrins are 
important for leukocyte traffcking, particularly the process 
of transmigration from blood into tissues, raised the possi- 
bility that PT might also interact with a eukaryotic system 
of cell-cell adherence proteins. 
PT is a hexameric toxin of the classical AB architecture 
(8). This toxin has two clearly distinguishable physiological 
effects that appear to involve separate mechanisms. The most 
well-known effect involves the ADP-ribosylation of G pro- 
teins by the A subunit leading to increased intracellular cy- 
1Abbreviations used in this loafer: FHA, filamentous hemagglutinin; PT, 
pertussis  toxin. 
clic AMP and eventual cellular dysfunction (8). The physio- 
logical hallmarks of this effect are sustained leukocytosis and 
histamine sensitization. For this effect the B oligomer (subunits 
$2, $3, $4, $5; 1:1:2:1) serves to confer cellular recognition 
properties for delivery  of the toxic A  subunit. In Chinese 
hamster ovary cells, the B oligomer appears  to bind to a 
165-kD sialylated glycoprotein, which then slowly (over hours) 
leads to the ADP-ribosylation by the A subunit of a 41-kD 
protein and the subsequent morphologic response of cell 
clustering (9). Distinct from this slow effect on eukaryotic 
cells is a second set of rapid effects that are attributable to 
the B oligomer and are completely independent of the A 
subunit, including mediation of adherence of the intact bac- 
teria to dlia, bacterial adherence and uptake into macrophages, 
and T cell mitogenicity (3, 7, 10). All known cellular recog- 
nition by PT is directed to carbohydrates  on eukaryotic cell 
surface proteins or lipids but the identification of a single 
receptor to explain  the rapid effects of the B oligomer has 
not been possible. Rather, it may be that there are multiple 
surface components on eukaryotic cells, that bear sialylated 
and nonsialylated carbohydrate determinants for binding of 
the B oligomer (7,  10-12).  Binding of the B oligomer to 
T  cells in a sialic acid-dependent fashion mediated by the 
$3-$4 dimer leads to the rapid downregulation of the TCR 
CD3  (13). In contrast, binding of the B oligomer by the 
$2-$4 dimer to T cells in a non-sialic acid-dependent fashion 
to a 43-kD T cell protein leads within seconds to the genera- 
tion of inositol triphosphate, diacylglycerol, and increased cyto- 
solic free calcium independent of the TCR CD3 or CD28 
(10). These effects suggest that the B oligomer of PT can 
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nism than inactivation  of G  proteins and that  some of the 
resulting  effects could alter cellular adhesion properties. 
Recognition of eukaryotic cells by the B oligomer is medi- 
ated by the carbohydrate recognition domains of subunit $2 
(21,925 dahons) and the 80% homologous subunit $3 (21,873 
dahons). Localization and structural requirements for ligand 
binding by these lectin domains has been accomplished using 
recombinant subunits, extensive site-directed mutagenesis, and 
antibody mapping studies (6, 14-18). Although the precise 
residues that  have various carbohydrate binding  properties 
differ between each assay in each laboratory, a common theme 
has emerged implicating the 50 NH2-terminal residues and 
a region roughly spanning residues 90-120 as having strong 
effects on carbohydrate recognition. All carbohydrate recog- 
nition  can be abolished by mutation  of $2 residues Arg 92, 
Asn  93, or Asn 1~  or $3 Lys  1~  (6,  18). Mutation of a second 
region  of the subunits extending between residues 37 and 
52 causes alteration of carbohydrate specificity between lac- 
tose or sialic acid (6). We have focused on this latter region 
for two reasons:  a) loss of carbohydrate binding  as shown 
for other regions can be a nonspecific effect due to alteration 
of tertiary structure, while changing of carbohydrate target 
specificity is a property compatible with a region at or very 
near an actual binding site, and (b) this region shows sequence 
similarity with the eukaryotic C-type lectin family (6). We 
reasoned that the coincidence of this structural similarity with 
the rapid effects of the B oligomer on leukocytes might indi- 
cate that PT subunits have properties of the selectins, the subset 
of C-type lectins that mediate leukocyte-endothelial cell in- 
teractions  (19). 
Three selectins have been characterized and all share a ter- 
minal  lectin domain.  P-Selectin  (GMP-140)  and E-selectin 
(ELAM-1) appear on activated endothelial cells and mediate 
adherence of leukocytes by recognition of sialylated and non- 
sialylated determinants (20-24). L-Selectin (human leukocyte 
homing  receptor;  hLHR)  is  present  on  lymphocytes and 
mediates homing to lymphoid tissue bearing sialylated glycon- 
jugates (25).  Selectins play an important  roll in promoting 
the margination  and reversible rolling of leukocytes at sites 
of tissue inflammation.  Upon ligation of selectins,  neutro- 
phils rapidly upregulate the integrin  CD11b/CD18,  which 
then promotes the transition from leukocyte rolling to trans- 
migration  (24, 26).  Since FHA binds to CD11b/CD18  (4) 
and the B oligomer of PT rapidly promotes FHA-mediated 
bacterial uptake by this receptor (7), it appeared reasonable 
to investigate if PT subunits had selectin-like  properties. Fur- 
thering  the rationale  to focus this line of investigation  on 
the carbohydrate recognition domain in the NH2-terminal 
region of $2 and $3 was the observation that carbohydrate 
binding properties have recently been attributed to the NH2- 
terminal region of E-selectin (27), and peptides patterned after 
residues 23-63 of P-selectin inhibit leukocyte adherence to 
P-selectin-coated substrates  (28,  29).  We present  evidence 
herein that the lectin domains of $2 and $3 of pertussis toxin 
are structural and functional analogues of the lectin domains 
of eukaryotic selectins. 
Materials and Methods 
Recombinant Subunits and Peptides.  FF and B oligomer (List Bio- 
logicals, Campbell, CA) were tested as purified proteins. Recom- 
binant  subunits $2, $3, $4, and $2 subunit  analogues with site- 
specific amino acid substitutions  and chimeric subunits  with $2 
containing $3 residues 31-54 ($2/$3) or $3 containing $2 residues 
31-61 ($3/$2) were generated as described previously (6, 30, 31) 
and tested as inclusion body preparations standardized to 50 ~g/ml 
of the desired protein. 
12 peptides derived from the region of sequence similarity shown 
in Fig. 1 were synthesized. Using residue sequences as shown in 
Fig. 1, these peptides were: P-selectin 24-38 and 27-46; E-selectin 
24-38, 27-45, and 32-45; L-selectin 24-38 and 27-45; $2 28-45, 
32-53, and 39-53; $3 28-45  and 39-53. A peptide of scrambled 
$2 sequence SQLRVILLEAGETLAYGDL was used as a control. 
Selectin t-Butoxycarbonyl (t-BOC) peptides were synthesized on 
a peptide synthesizer (430; Applied Biosystems, Inc., Foster City, 
CA) using  standard t-BOC/bicyclohexyl-carbodiimide/dichloro- 
methane coupling chemistry. Syntheses were performed at the 0.5- 
mmol scale using standard t-BOC amino acids with the following 
side chain protecting groups: Arg (tousenesulfenyl), Asp (Obenzyl), 
Cys (4-methylbenzyl), Glu (OBenzyl), His (dinitrophenyl), Lys (2- 
chlorobenzyloxycarbonyl), Ser (benzyl), Thr (benzyl), and Tyr (2- 
bromobenzyloxycarbonyl).  All histidine, glutamine, arginine, and 
asparagine residues were double coupled.  The relevant COOH- 
terminal  amino  acid-coupled  4-(carboxamidonethyl)benzyl  ester 
linked polystyrene was used as the starting  resin. The final resin 
was dried and subjected to hydrofluoric acid cleaveage  and deprotec- 
tion. The cleaved, dried peptide was purified to >90% purity by 
I-IPLC using a 300-A  pore size, 1 x  25-cm reverse-phase column 
(C4;  Vydac, Hesperia,  CA)  with  binary  gradients  of 0.05% 
TFA/acetonitrile  and 0.1%  TFA/water,  and lyophilized. Amino 
acid compositions were verified  on an amino acid composition system 
(420A/130A/920A;  Applied Biosystems, Inc.). 
Adherence~176176176  Terasaki  tissue 
culture plates were coated with 10/~g/ml  E-selectin (courtesy of 
R. Lobb, Biogen,  Cambridge,  MA [23]) or P-selectin (courtesy 
of R. McEver, University of Oklahoma,  Oklahoma City, OK [20, 
28]), then blocked with albumin (5 mg/ml), washed, and incubated 
for 10 rain at 37~  with 10 ~g/ml of purified PT or B oligomer, 
recombinant  purified $2, $3, or $4, $2 analogues containing  site- 
specific mutations, or 1 mg/ml synthetic peptides. LPS (10 #g/ml) 
was tested as a control for residual endotoxin  in inclusion body 
preparations  of recombinant  subunits.  Human neutrophils  were 
isolated according to the manufacturer's specifications using neu- 
trophil isolation medium (Cardinal Associates, Santa Fe, NM). Neu- 
E-selectin  15  ~ay~hqryt~l  ~  ~~lils~  45 
L-selectin  ~5~rrf~dnytd~l ~a~k  ~i~k  tiffs  I 4s 
s3  19  ~gr~ngtr~L~1~]~t~l~qitp~ws[  ~3 
P-selectin  15  ~rky~nryt~L I  ~a~qhM I;~  d~l~kvlp~ys  I 46 
S2  19  pygr~J~nktra~e~~rhvtrg~  s3 
Figure  1.  Sequence comparison of the  NH2-terminal regions of 
subunits $2 and $3 of PT and the selectins. Sequences  were aligned ac- 
cording to the algorithm of Needleman and Wunsch (34) using the GENA- 
LIGN program, resulting in an alignment score of 68. Boxed  residues are 
those conserved  among the proteins and residues in capital letters indicate 
identity with the consensus sequence  of the C-type lectins (CRD) as de- 
fined by Drickamer (35). Shaded regions are predicted to be c~ helical 
(MICROGENIE program). 
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lowed to adhere for 30 min at 37~  The plate was then inverted 
for 10 min and rinsed by brief submersion in buffered saline. The 
number of neutrophils  adherent to the surfaces in a 40x  micro- 
scope field was quantitated and expressed as a percentage of adher- 
ence in buffer taken as 100%. Repetition of the assay with the sub- 
stitution of albumin for the selectin used in coating the surfaces 
revealed no effect on leukocyte adherence by any FT component 
tested, indicating the effects  observed  with the selectins  were specific. 
Upregulation of the Integrin CDllb/CDI8 on Neutrophils.  Neu- 
trophils (5/A of 106 cells/ml) were allowed to spread for 30 min 
at 37~  in Terasaki tissue culture wells. Adherent neutrophils were 
exposed to 5 #1 of PT subunit (50 #g/ml), synthetic peptides (0.5 
mM), LPS (10 #g/ml), or fNLLP (5  x  10 -s M) for 30 min at 
37~  After aspiration of the supernatant fluid, 5 #1 of C3bi-coated 
erythrocytes (107 ceUs/ml; C3bi is a specific ligand for the inte- 
grin CD11b/CD18 [32]) were added for 30 min at 37~  Uncoated, 
IgM-  or IgG-coated  erythrocytes  were  used as  controls.  After 
washing, the number of erythrocytes bound per 100 leukocytes (ad- 
herence index) was quantitated  visually under an inverted micro- 
scope. Intoxication of the leukocytes by PT did not affect the assay 
results during the 30-rain incubation period tested since induction 
of enhanced adherence of C3bi-coated erythrocytes by fNLLP was 
equivalent in the presence or absence of PT (basal value of 296 in- 
creased to 1,628 or 1,265 particles/100 leukocytes, respectively). 
Adherence of Neutrophils to Cultured Endothelial Cells.  Human 
umbilical vein endothelial cells (first passage; Clonetics, San Diego, 
CA) were subcultured  at confluence into Terasaki tissue culture 
wells. After 24 h, confluent monolayers were used for adherence 
assays (26). Monolayers were stimulated with  10 ng/ml TNF-c~ 
(Boehringer Mannheim Biochemicals, Indianapolis, IN) at 37~ 
for 4 h  to induce  expression of E-selectin. Human neutrophils 
(106/ml) were labeled with fluorescein (26), and preincubated for 
15 min at 37~  with peptides (0.5 mM in HAP [PBS containing 
0.5 mg/ml human serum albumin, 3 mM glucose, and 0.3 U/ml 
aprotinin])  or HAP as a control buffer. For some experiments, 
selectin- vs. integrin-mediated adherence was differentiated by also 
preincubating  the neutrophils with 50 #g/ml of the antibody IB4 
against the CD18 integrins (33). Neutrophils were allowed to ad- 
here to the monolayer for 15 min at 37~  and unbound cells were 
removed by submersion of the plate in saline buffer. The number 
of adherent neutrophils was counted in a 40x microscope field and 
expressed as a percentage of adherence in control wells with neu- 
trophils  treated  with HAP buffer alone. 
Results 
Similarity of Sequence of Subunits $2 and $3 and the Selectins. 
The amino acid sequence of the NHz-terminal regions of the 
lectin domains of the selectins and the carbohydrate recogni- 
tion domains of $2 and 53 were compared. Significant se- 
quence similarity was observed between PT subunit residues 
19-52 and selectin residues 15-46 (Fig. 1). A strong predic- 
tion of c~-helical structure for >10 sequential residues was 
found for residues 28-40 of E-selectin, 27-43 of L-selectin, 
and 33-42 of $3; shorter oe-helical regions were predicted for 
P-selectin 29-35 and $2 35-46 (Fig. 1). Based on these similar- 
ities, purified subunits $2 and $3, analogues of the subunits 
containing site-specific mutations, and peptides corresponding 
to the region in Fig.  1, were made and tested in assays of 
selectin function in vitro and in vivo. 
The Ability of  Purified Su~nits and Subunit Analogues to Block 
Leukocyte Adherence to Selectins and Upregulate Integrins.  In 
view  of the  apparent  structural  similarities  of the  NH2- 
terminal regions of $2 and 53 to E-selectin and P-selectin, 
we tested PT, B  oligomer, and individual PT subunits for 
functional selectin-like activity in vitro. Neutrophils adhere 
avidly to substrates coated with E-selectin and P-selectin; PT 
and B oligomer were highly effective competitive inhibitors 
of this interaction, competing in a dose-dependent manner 
(Fig.  2).  The maximum inhibition of leukocyte adherence 
to both selectins by the B  oligomer was  "~75%  and was 
achieved at concentrations of 2 #M (150/~g/ml). Substantial 
inhibition of adherence (>25%) was still evident at concen- 
trations of 130 nM  (10/~g/ml). 
To examine the specificity of this inhibition of adherence, 
the effects ofB oligomer were compared with isolated subunits 
and  subunit chimeras (Fig.  3).  Inhibition of adherence to 
P-selectin equivalent to that seen with 130 nM of the native 
B oligomer was achieved by 30 nM (10/~g/ml) of partially 
purified 52 (27  _+  3%); 53 was consistently less effective (2 
_  9%).  Conversely, inhibition of neutrophil adherence to 
E-selectin equivalent to that seen with 130 nM of the native 
B oligomer was achieved by 30 nM (10/~g/ml) of partially 
purified $3 (36  _+  5%); $2 was consistently less effective (9 
_+  7%). These effects were dependent on the amino acid se- 
quence of the lectin domain of the subunits since chimeric 
subunits having interchanged carbohydrate recognition do- 
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Figure 2.  Inhibition  ofneutrophil  adherence  to selectin-coated  substrated 
by the B oligomer  of FT. Substrates were  coated  with 10/ig/ml E-selectin 
(filled circles) or P-selectin (open circles), washed, and incubated with the 
indicated concentrations  of B oligomer. Neutrophils  were allowed to ad- 
here for 30 min at 37~  and then rinsed. The number of neutrophils ad- 
herent to the surfaces in a 40x microscope  field was quantitated and ex- 
pressed as a percentage  of adherence  in buffer  taken as 100%; values are 
mean  _+  SD of triplicate experiments with duplicate wells. 
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Figure 3.  Inhibition of adherence  of polymorphonuclear  leukocytes  to 
selectin-coated substrates by PT and PT subunits. Substrates were coated 
with E-selectin (stippled  bars) or P-selectin (hatched bars). The indicated PT 
subcomponent, recombinant $2, $3. or $4, or LPS (10 #g/ml) were added 
followed  by polymorphonuclear  leukocytes;  $2/$3 indicates $2 containing 
$3 residues 31-54; $3/$2 indicates 53 containing $2 residues 31-61. The 
number of polymorphonuclear leukocytes adherent to the surfaces in a 
40x microscope  field was quantitated and expressed  as a percent of adher- 
ence in buffer (control); values are means _+ SD of four experiments  testing 
each condition in triplicate wells. 
mains (residues 31-54) switched inhibitory efficacy (Fig. 3). 
Moreover, the ability of 150 nM $2 to inhibit leukocyte ad- 
herence to E-selectin could be enhanced from 5  _+  9%  to 
as much as 61  _+  6% by site-specific mutations at residues 
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Figure 4.  Ability of $2 analogues to inhibit adherence  of neutrophils 
to E-selectin.  Purified  recombinant analogues  were tested as inclusion  body 
preparations standardized to 50 #g/m[ (150 riM) of the desired protein 
added to E-selectin-coated  substrates 10 min before neutrophils (as in Fig. 
3). $2/$3 indicates $2 containing $3 residues 31-54; $3/$2 indicates $3 
containing $2 residues 31-61. Analogues with the indicated substitutions 
at residues Glu  43, Tyr  44, Leu  4s, Arg  s~ and Gly  sl (arrows) bind sialylated 
glycoconjugates while the remaining analogues recognize the native $2 
ligand lactosylceramide  or neither carbohydrate (6). Values represent the 
means  +  SD of the number of neutrophils adherent to triplicate wells 
as viewed by a 40x microscope field expressed as a percent of adherence 
in buffer (control). 
Glu  43,  Tyr  ~  Leu  4s, Arg  5~  and Gly  sl  (Fig. 4),  the residues 
known to change the carbohydrate specificity of $2 from non- 
sialylated to the sialylated ligands  preferred by $3. 
Under certain conditions, when neutrophils engage selectins 
on the surface of activated endothelial cells, integrins of the 
CDll/CD18  family are rapidly upregulated on the neutro- 
phil surface. Subunits $2 and $3 (50 #g/ml,  150 nM) were 
as effective as fNLLP, PT, and native B oligomer at enhancing 
the binding of a CDllb/CD18 ligand (C3bi-coated erythro- 
cytes) to neutrophils  (>300%  of control;  Fig.  5);  subunit 
$4 was ineffective. LPS at a concentration representative of 
the level of contamination of the subunit preparations was 
also ineffective, as expected in assays  performed in  the ab- 
sence of serum.  These effects were independent  of the  A 
subunit of the toxin as indicated by the equivalent response 
to PT and B  oligomer.  Furthermore,  the upregulation  oc- 
curred within 30 min of exposure to the IT/' subcomponents 
as opposed to the time frame of hours for the ADP-ribosylation 
effects of the holotoxin. This result indicates that concentra- 
tions of the subunits  that  inhibit leukocyte attachment  to 
selectins also cause rapid and significant upregulation of the 
CD11b/CD18  integrin. 
The Ability of $2 and $3 Peptides  to Block Leukocyte Adher- 
ence to Selectins  or Endothelial Cells vs.  Upregulate Integrins In 
Vitro.  Various peptides derived from residues 24-45 of the 
native selectins or from the corresponding region 28-53 of 
$2 and $3 were synthesized and tested in vitro for two selectin 
functions:  the  ability  to  inhibit  neutrophil  adherence  to 
E-selectin and upregulate the leukocyte integrin CDllb/CD18. 
Peptides corresponding to the COOH-terminal  half of the 
lectin  domains  of Fig.  1  were  uniformly  less  effective at 
blocking leukocyte adhesion but retained strong activity for 
upregulation of the CDllb/CD18  integrin (Table 1). Thus, 
peptides corresponding to the NH2-terminal half of the re- 
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Figure 5.  PT subunits f~nctionaUy  upregulate  the integrin CD11b/CD18 
on neutrophils. Neutrophils adherent to plastic substrates were exposed 
to PT subunit (50/~g/ml), LPS (10 #g/ml) or fNLLP (5  x  10 -s M) for 
30 min, washed, and adherence of C3bi-coated erythrocytes was quanti- 
tated as an indicator of the function of the CD11b/CD18 integrin. Values 
indicate the means + SD of the number of erythrocytes attached to 100 
leukocytes (adherence  index) in each of triplicate wells; data are represen- 
tative of three experiments. 
920  Bacterial  Selectin-like Peptides Table  1.  Ability of PeFtides Derived from Selectins or PT Subunits  to Block Neutrophil  Adherence to E-Selectin-coated Sue'aces and to 
Upregulate the Integrin CDI I b/CD18 
Percent change from control 
Leukocyte  EC3bi 
Peptide"  binding*  bindings 
E-selectin 
32KEEIEYLNSILSYS  45 
=TVAIQNKEEIEYLNSILSYS  45 
uTHLVAIQNKEEIEYL  3s 
L-selectin 
~TVAIQNKAEIEYLEKTLPFS  45 
24TDLVAIQNKAEIEYL  3s 
P-sel~tin 
27VAIQNKNEIDYLNKVLPYYS  46 
$2 
39GDLQEYLRHVTRGWS  53 
32VAELRGSGDLQEYLRHVTRGWSSa 
~RALTVAELRGSGDLQEYL  45 
$3 
39AELQTYLRQITPGWS  5~ 
~RALTVAELRGNAELQTYL  ~5 
-2  -+  5  +243 
-35  __.  11  +71 
>-  50  + 73 
-  26  _+  5  +  163 
>- 50  + 104 
-9  _+  6  +113 
-7  _+  7  +232 
+27  _+  5  +48 
> -  50  + 104 
-9  +_  8  +201 
>-  50  + 122 
* Peptides are offset to highlight  regions of overlap. 
t Leukocytes were added to wells coated with E-selectin in the presence of 0.5 mM of peptide. Values are the percent of inhibition of attachment 
as compared with control wells receiving buffer alone and are mean  +_  SD of triplicate experiments. 
S Erythrocytes coated with C3bi (EC3bi) were incubated with leukocytes pretreated with 0.5 mM of peptide. Values are the percent of increase 
in attachment  as compared with control wells pretreated with buffer alone and are representative of triplicate experiments. 
gion were tested in more detail with the aim of identifying 
an antiinflammatory peptide that would inhibit leukocyte ad- 
herence without strong upregulation of CD18-dependent leu- 
kocyte transmigration. 
10 peptides were tested for the ability to block leukocyte 
adherence to monolayers of human umbilical vein endothelial 
cells. A scrambled $2 peptide served as a control and demon- 
strated very low activity (Fig. 6). Since leukocytes can adhere 
to activated endothelia by selectin- or integrin-mediated events, 
some assays were conducted in the presence of the anti-CD18 
antibody IB4 to distinguish the contribution of integrins to 
the observed adherence. Fig. 6 depicts a comparison of the 
abilities  of the peptides to inhibit leukocyte adherence to ac- 
tivated endothelia. The three $2 peptides showed an inhibi- 
tory activity of 39  --  12 to 44  __  2%, with no significant 
differences in activity between them. In contrast, $3 28-45 
was highly inhibitory (48  +  11%)  while the more down- 
stream peptide $3 39-53 was ineffective. The two E-selectin 
peptides were somewhat more effective than the analogous 
P-selectin peptides. The three most effective peptides were 
$2  and  $3  28-45  and E-selectin 32-45. 
When the peptides were compared for the ability to up- 
regulate the leukocyte integrin CDllb/CD18,  it could be 
shown that the peptides modeled after more COOH-terminal 
regions induced upregulation of the integrin by as much as 
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Figure 6.  PT peptides inhibit adherence of neutrophils to endothelial 
cells. Fluoresceinated  neutrophils were incubated with peptides (0.5 mM) 
in HAP buffer; peptides are designated by the numbers of the first and 
last residues  as in Fig. 1. Control cells  were treated with HAP buffer alone. 
Without washing, the neutrophils were allowed to adhere to confluent 
monolayers of human endothelial cells. After washing, the number of ad- 
herent neutrophils was counted per 40x  microscope field and expressed 
as a percentage of adherence in the control HAP wells (mean of 63  _+ 
9 neutrophils/field), Values  represent mean _+ SD of triphcate experiments 
with triplicate wells. 
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Figure 7.  PT peptides  upregulate  the leukocyte  integrin  CDllb/CD18. 
Neutrophils adherent  to plastic surfaces  were  incubated  with peptides  (0.5 
mM); peptides  are designated  by the numbers of the first and last residues 
as in Fig. 1. The cells were  washed and overlaid  with erythrocytes  coated 
with C3bi (EC3bi), a specific  ligand for CDllb/CD18. After washing 
away unbound EC3bi, the number of EC3bi per 100 leukocytes  (adher- 
ence index) was determined  under an inverted  microscope.  Values repre- 
sent the mean +_ SD of triplicate experiments with triplicate wells. 
200%  of control values  (Fig.  7).  In contrast,  three NH2- 
terminal peptides ($2  and $3  28-45  and E-selectin 24-38) 
upregulated the integrin significantly less (<50% of resting 
control levels). Thus, the same $2 and $3 peptides found to 
be most effective at blocking leukocyte adherence to endothelial 
cells  shared the lowest ability to upregulate the integrin. 
Discussion 
A  number of parallels  can be drawn between the struc- 
ture/function analyses of the prokaryotic lectins $2 and $3 
of PT and the eukaryotic sdectins. Among the carbohydrates 
recognized by PT subunits $2 and $3 are the sialylated Lewis 
x determinant and its nonsialylated relative, the Lewis a de- 
terminant (14).  This affinity pattern is reminiscent of that 
of the selectin pair,  E-selectin and P-selectin. Carbohydrate 
recognition appears  to be a property of the NH2 termini of 
subunits $2 and $3 as evidenced by the ability to alter the 
specificity of carbohydrate recognized by the subunits upon 
mutational alteration of residues 28-52  (6) and the ability 
of a peptide from $2 9-23 to directly bind to simple sialylated 
saccharides (17).  Similarly, mutational  alteration of NH2- 
terminal residues 7, 8, and 9 or the 43-48 loop of E-selectin 
either abolished or enhanced carbohydrate binding ability of 
the protein (27).  Conservation of lysine at positions 111 and 
113 of E-selectin and lysine 105 of $3 are critical for lectin 
function (6, 18, 27). Upon more detailed comparison of the 
amino  acid sequences of the NH2-terminal region of the 
prokaryotic and eukaroytic proteins, significant similarity was 
apparent between all three selectins and the two lectin subunits 
of PT. Over a span of 25 residues (19-53) of the PT subunits 
and 22 or 23 residues (15-45 or 15-46) of the selectins,  nine 
positions of identity and two positions of conservative sub- 
stitution were found. E-Selectin, L-selectin, and $3 shared 
strong predictions of extensive or-helical structure in the regions 
of the biologically active peptides; shorter regions were found 
in P-selectin and $2. Taken together, the similarities of pri- 
mary sequence, tertiary structure, and general functional re- 
quirements of the prokaryotic and eukaryotic proteins sug- 
gested that these proteins might have similar physiological 
effects. 
Selectins on activated endothelia rapidly and reversibly cap- 
ture surface carbohydrates of leukocytes in the process of leu- 
kocyte rolling at sites of inflammation (19). This selectin- 
carbohydrate interaction also rapidly triggers the upregula- 
tion of a second leukocyte adhesion molecule, the CDllb/ 
CD18 integrin (26). The B oligomer of PT (independent of 
the ADP-ribosyltransferase activity of the A subunit) is also 
known to bind to leukocyte carbohydrates and rapidly in- 
duces signal transduction leading to such effects as mitoge- 
nicity (10) and enhancement of bacterial uptake by CDllb/ 
CD18 (7).  The shared features of a rapid effect targetted to 
leukocyte carbohydrates and the CDllb/CD18  integrin are 
consistent with the hypothesis that the selectins and PT lectins 
may use similar structural motifs to achieve common effects 
on leukocyte function. 
The B oligomer, individual subunits $2 and $3, and pep- 
tides from the $2 and $3 lectin domains strongly inhibited 
leukocyte adherence to selectin-coated surfaces. B oligomer 
was equally effective against the P- and E-selectin with 50% 
inhibition at ,'o0.5 #M.  The individual $2 subunit demon- 
strated greater activity against P-selectin and the $3 subunit 
showed greater activity against the E-selectin. This prefer- 
ence was a property, at least in part, of the region 19-53 of 
these proteins since chimeric subunits containing swap mu- 
tations caused a parallel shift in the preferred selectin targetted 
by the subunit and individual site mutations at residues 43, 
44, 45, 50, and 51, which caused $2 to switch carbohydrate 
affinity to that of $3, also improved the ability of $2 to in- 
hibit leukocyte adherence to E-selectin. This is further sup- 
ported by the ability of peptides derived from the 19-53 lectin 
domain of the subunits to block adherence of leukocytes to 
selectin-coated surfaces. Strong inhibition of adherence was 
evident for peptides derived from the more NH2-terminal 
half of this region while the second selectin function of up- 
regulation of the integrin CD11b/CD18  was a property of 
all peptides throughout the region, indicating the possibility 
of dissociating the structural requirements for these two phys- 
iologic responses. These findings are consistent with the ability 
of the P-selectin peptide  19-43,  which overlaps  with  the 
NH2-terminal portion of the homologous domain studied 
here, to strongly inhibit leukocyte adherence to P-selectin- 
coated surfaces  (90%  inhibition  at 0.5  mM vs.  $3  28-45 
>50%  inhibition at 0.5  mM) (29). 
When neutrophils engage selectins on the surface of acti- 
vated endothelia, integrins are rapidly upregulated on the neu- 
trophil surface in order to effect transmigration of the neu- 
trophil across the endothelial barrier (26).  PT subunits not 
only acted as competitive analogues of selectins in leukocyte 
adherence assays, but also strongly upregulated the CDllb/ 
CD18 integrin on the neutrophil surface. CD11b/CD18 ac- 
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values,  an increase comparable to the well-known activator 
fNLLP. Upregulation of the integrin function was seen for 
the B oligomer, the individual subunits (especially $3), and 
for the peptides from the subunit lectin domains; on a molar 
basis the purified subunits were fourfold more effective than 
the B oligomer. Most FT peptides were as effective as native 
selectin peptides in this function, with the notable excep- 
tions of $2 and $3 28-45 and E-selectin 24-38. These latter 
three peptides showed less ability to affect integrin function 
than their respective more COOH-terminal peptides. This 
was particularly evident for the $3 peptide, which showed 
virtually no upregulation of the integrin. 
The ability of the B oligomer of PT to function in a selectin- 
like manner, particularly the upregulation of CDllb/CD18, 
is of potential importance to the biology of pertussis infec- 
tion. Pretreatment of macrophages with cell-free B oligomer 
enhances bacterial binding to the CDllb/CD18  integrin by 
the adhesin FHA,  resulting in greater uptake and survival 
of bacteria intracellularly (7). The upregulation of the CDllb/ 
CD18 integrin shown here by the B oligomer, subunits $2 
and $3, and the subunit peptides is consistent with and pro- 
vides a mechanism for this observed activation of the inte- 
grin by pertussis toxin released from bacterial cells. Thus sub- 
version of the selectin- and integrin-based systems provides 
bacterial entry into a second environmental niche in the lung, 
which prolongs the length of colonization (5) and is com- 
patible with the 6-wk course of infection, which extends 4 
wk beyond the documented time of bacterial adherence to 
its primary niche on ciliated respiratory epithelial cells. It is 
not likely that these transient selectin-like effects contribute 
to the substantial abnormalities in leukocyte trafficking char- 
acteristic of whooping cough since the intoxication of leu- 
kocytes by ADP-ribosylation by the A subunit of PT is known 
to be the overwhelming cause of the characteristic circulating 
leukocytosis in this infection. 
The process of leukocyte adherence to endothelial cells in- 
volves at least two sequential steps, the selectin-mediated re- 
versible association, which allows leukocytes to roll along an 
endothelial surface, and the second CD18 integrin-mediated 
step, which promotes stable association of the leukocyte with 
the endothelium before transmigration. The ability of selectins 
to upregulate integrin function presumably contributes to 
the proper sequential activation of these steps. However, in 
the design of an antiinflammatory agent it would be desir- 
able to dissociate the two steps  such that selectin-mediated 
rolling could be competitively inhibited without triggering 
leukocyte adhesion by integrins. The dissociation of the ac- 
tivities of blocking leukocyte adherence to selectins and up- 
regulation of the CDllb/CD18  integrin in the studies with 
the PT and selectin peptides suggested that these peptides 
might effectively block leukocyte adherence to endothelial 
cell monolayers, an in vitro system in which both selectin- 
and integrin-mediated mechanisms can be demonstrated to 
contribute to adherence. The $2 and $3 28-45 peptides, which 
upregulated the integrin the least while strongly blocking 
adherence of neutrophils  to  selectin-coated surfaces,  were 
highly effective inhibitors of leukocyte adherence to activated 
endothelia. Based on the in vitro studies presented here, the 
peptides predicted to have the greatest net antiinflammatory 
effect are $2 and $3 28-45,  the prokaryotic variants of the 
native selectin sequences.  The identification of prokaryotic 
members of the selectin family expands the range of possibil- 
ities for development of selectin analogues with potential ther- 
apeutic value. 
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